Overall, the global infusion therapy market was valued at $11.7 billion in 2023, a 4.5% increase from $11.2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 3.7% to reach $15.0 billion. Currently, the global infusion therapy market is dominated by Becton Dickinson (BD) and B. Braun. Throughout

iData’s global vascular access MedSuite covers 8 markets including implantable ports, needles, and syringes. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

In 2022, the European Infusion Therapy Device Market size was valued at $1.1 billion. By the end of the forecast period, the market size is expected to increase to reach a value of at least €1.3 billion by 2029. Throughout this medical market research, we analyzed 46 infusion therapy companies across Europe and used our

iData’s U.S. vascular access MedSuite covers 15 markets including implantable ports, needles, and syringes. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s European vascular access MedSuite covers 13 markets including implantable ports, needles, and syringes. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s Canadian vascular access device MedSuite covers 14 markets including the acute central venous catheters (CVCs), peripherally inserted central catheters (PICCs) markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

The Infusion Therapy Device Market in the United States had a valuation of $3.0 billion in 2022. With a projected compound annual growth rate (CAGR) of 2.5%, it is estimated to surpass $3.6 billion by the end of the forecast period. Throughout this medical market research, we analyzed over 40 Infusion Therapy companies across the

This global market research spans over 70 countries and includes the global market for blood transfusion devices.

This global market research spans over 70 countries and includes the global market for stopcocks.

This global market research spans over 70 countries and includes the global market for intravenous filters.

This global market research spans over 70 countries and includes the global markets for pump sets, secondary sets, gravity sets and extension sets.

The full report suite on the global market for intravenous (IV) sets includes pump sets, secondary sets, gravity sets and extension sets.

This global market research spans over 70 countries and includes the global markets for Large Volume Pumps, Syringe Pumps, Patient-Controlled Analgesia Pumps, Electronic Ambulatory Pumps, and Disposable Ambulatory Pumps.

iData’s global syringe and needle market MedCore covers both the needle market and the syringe market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

The full report suite on the Australian market for infusion therapy devices includes infusion pumps, intravenous sets (IV sets), needleless connectors (NLCs), stopcocks for infusion systems and infusion sets designed for blood transfusion (blood transfusion sets).

The full report suite on the Japanese market for infusion therapy devices includes infusion pumps, intravenous sets (IV sets), needleless connectors, stopcocks for infusion systems and infusion sets designed for blood transfusion (blood transfusion sets).